Date: 2014-10-23
Type of information: Resignation
Compound:
Company: Raptor Pharmaceuticals (USA - CA)
Therapeutic area:
Type agreement: resignation
Action mechanism:
Disease:
Details: * On October 23, 2014, Raptor Pharmaceutical announced that Georgia Erbez, Chief Financial Officer since September 2012, will be leaving the company to pursue other opportunities. Frank Lanza has been appointed as interim Principal Financial and Accounting Officer. Mr. Lanza has served as the company\'s Controller since February 2013. Raptor has initiated a process to select a new Chief Financial Officer.
Financial terms:
Latest news:
